Navigation Links
Actos Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Actos Bladder Cancer Litigation
Date:7/21/2013

New York, New York (PRWEB) July 21, 2013

Actos lawsuit claims involving allegations that the drug caused users to develop bladder cancer continue to move forward in a multidistrict litigation now underway in U.S District Court, Western District of Louisiana, Bernstein Liebhard LLP reports. According to court documents, the Actos bladder cancer litigation’s next Status Conference has been scheduled for Thursday, July 25th. An update issued by the U.S. Judicial Panel on Multidistrict Litigation on July 10th indicated that more than 2,400 Actos lawsuits are now pending in the consolidated proceeding. (In re: Actos Product Liability Litigation, MDL No. 2299)

“We continue to hear from individuals seeking to file Actos lawsuits that allege the drug caused their bladder cancer. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos bladder cancer lawsuit evaluations to patients who developed the disease after using the medication for an extended period of time

Actos Bladder Cancer Lawsuits
Actos lawsuits pending in the Western District of Louisiana accuse Takeda Pharmaceuticals of concealing knowledge that use of the type 2 diabetes treatment was associated with an increased risk of bladder cancer, and failing to provide adequate warnings to patients and doctors regarding this risk. According to court documents, the first trial in the federal Actos litigation is scheduled to begin on January 27, 2014.

In April, the nation’s first trial involving Actos bladder cancer allegations ended with a Los Angeles Superior Court jury awarding $6.5 million to a plaintiff who was diagnosed with the disease after taking Actos for four yea
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
2. Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
3. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
4. Researchers Offer Explanation for Actos Bladder Cancer Risk
5. New Lawsuit alleges Actos caused Bladder Cancer
6. US Drug Watchdog Now Urges Family Members Of A Diabetic Who Died From Bladder Cancer After Using The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
7. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
8. US Drug Watchdog Now Urges Any US Citizen Who Used the Diabetes Drug Called Actos and Then Developed Bladder Cancer To Contact The Johnson Law Group For A Legal Review
9. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About the Diabetes Drug Actos and Bladder Cancer, with the Suggestion Victims Call the Johnson Law Group
11. US Drug Watchdog Now Urges Any Diabetic Who Used the Diabetes Drug Actos and Now Have Been Diagnosed with Bladder Cancer to Call The Johnson Law Group-ASAP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Dr. Dental is excited to announce the redesign of ... mind, one of the main differences from the old website ... very easy. Dr. Dental is renowned for having exceptional customer ... affordable, convenient and fun, and the new website mirrors these ... scheduling system right on the home page where a visitor ...
(Date:7/22/2014)... United Benefit Advisors (UBA), the nation's ... McPhearson, an insurance veteran with more than 15 years ... be based in the company's Chicago office. , UBA ... Les chose to accept this important, strategic position with ... many challenges facing UBA and its Partners as we ...
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... that break up blood clots deep in the veins of ... However, one results in a greater risk of bleeding and ... the other treatment, a new study finds. The standard ... (DVT) -- is blood-thinning medications and compression stockings. The other, ...
(Date:7/22/2014)... of Hematology (ASH) will honor Michael DeBaun, MD, MPH, ... Hebbel, MD, of the University of Minnesota Medical School ... their significant research advances in the area of sickle ... the late Ernest Beutler, MD, a past president of ... a two-part lectureship that recognizes major translational advances related ...
(Date:7/22/2014)... E. Marc, Ph.D., director of research at the University ... named by the International Society of Eye Research (ISER) ... Foundation,s 2014 Paul Kayser International Award in Retina Research., ... who has made a significant contribution to the understanding ... presented this week at the ISER Biennial Meeting in ...
Breaking Medicine News(10 mins):Health News:Dr. Dental Reveals Exciting New Website 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 4Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 5Health News:Study Casts Doubt on Costly Treatment for Leg Clots 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2
... Fishies is Nordic Naturals newest product for children, the "ultimate ... tasting natural tangerine flavor. Perfect for two-year-olds and up, Nordic ... oil from anchovies and sardines, two sustainable sources of high ... 455 mg of fish oil and offers 136 mg of ...
... Jourdan Urbach, a senior at Roslyn High School, is at ... only 12 seniors nationwide to be named a "national" Toyota Community ... than 8,000 seniors from across the country were nominated by their ... year, honors the top 100 students in the U.S. who are ...
... 23 The European diabetes diagnostics market is poised ... (POC) tests offering tremendous growth potential. Heightened efforts to ... a key driver in market development. For instance, limited ... However, this challenge will be curtailed with more education ...
... ... for the Study of Subtle Energies & Energy Medicine will hold their 19th annual conference ... ... professionals will be interested in attending the 19th annual ISSSEEM Conference that will begin with ...
... ... , ... 23, 2009 -- Big Case Marketing, the global leader in marketing for dentists, dental marketing ... a Boston based coaching and consulting firm for dentists with advanced clinical training, has announced ...
... Dr. Steven Shoshany ... www.LivingwellNewYork.com , to coincide with an exciting new direction he is taking with his office ... ... Chiropractic care in New York City for more than 13 years in his SOHO office. He ...
Cached Medicine News:Health News:Nordic Omega-3 Fishies from Nordic Naturals Offers Quality EPA and DHA for Children with 'Kid Pleasin' Taste 2Health News:Toyota Awards $1 Million in Scholarships to 100 High School Seniors - Roslyn High's Urbach Named One of Only 12 'National' Winners; Receives $20,000 2Health News:Toyota Awards $1 Million in Scholarships to 100 High School Seniors - Roslyn High's Urbach Named One of Only 12 'National' Winners; Receives $20,000 3Health News:Frost & Sullivan: Self-Monitoring and POC Diabetes Tests Reveal Potential for Significant Growth, Boosting the European Diabetes Diagnostics Market 2Health News:Frost & Sullivan: Self-Monitoring and POC Diabetes Tests Reveal Potential for Significant Growth, Boosting the European Diabetes Diagnostics Market 3Health News:19th Annual ISSSEEM Conference to Have Richard Bartlett to Discuss the Physics of Miracles: Connecting to the Quantum Field 2Health News:One of a Kind Marketing and Sales Summit for Dentists Announced 2Health News:One of a Kind Marketing and Sales Summit for Dentists Announced 3Health News:New York City Chiropractor Announces New State-Of-The-Art Facility, Website 2
(Date:7/22/2014)... July 22, 2014 Elekta (NSE:EKTAb) and ... The Christie NHS Foundation Trust ( Manchester, UK ... consortium whose mission is to develop the clinical value ... therapy system. Such a system would, in principle, improve ... targets. "The Christie was an essential ...
(Date:7/22/2014)... 2014  PuraMed BioScience®, Inc., (OTCBB: PMBS), a ... and healthcare products, announced today that the company ... "We are pleased to sponsor Operation ... and Chairman of PuraMed BioScience. "Research shows that ... experience migraines much more frequently than the general ...
(Date:7/22/2014)...  July 22, 2014 The ... Reuters , the world,s leading provider of ... announced Cortellis Clinical Trials Intelligence , ... industry-first milestone with the documentation of more ... professionals with greater and quicker access to ...
Breaking Medicine Technology:The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 2PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 3Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3
... Dec. 7, 2010 LABS Inc., the premier transplant ... that Kevin M. Smith, Chief Operating Officer of the ... has joined the company,s Board of Directors.  Smith brings ... industries. In addition to his current role ...
... 80 percent of the surgeries performed in the U.S. put patients ... a brain monitor is not used by the anesthesiologist. ... book recently published by Dr. Barry Friedberg, an acclaimed anesthesiologist who ... in Michael Jackson,s death. "The simple use of a ...
Cached Medicine Technology:LABS Inc. Adds Life Sciences Industry Veteran Kevin M. Smith to Board of Directors 2Michael Jackson's Death Could Have Been Avoided With a Brain Monitor Says Anesthesiologist 2
Calcitonin RIA Kit...
... 1200's speed and accuracy allow clinical ... a timely manner - something everyone ... patients. In fact, the Rapidlab 1200 ... just one minute. Its maintenance-free, cartridge-based ...
... The Dornier Medilas D Fibertom is a 60 ... nm wavelength. The use of Diode Power Bar ... system ideal for endovenous laser treatment for varicose ... Medilas D Fibertom also includes unique safety features ...
... test studies the characteristic axies of ... however this 28 hue test ... Case comes with a transparent base ... includes laminated scoring template (approx 8 ...
Medicine Products: